REFERENCES
- Whitcup S M, Nussenblatt R B. Immunologic mechanisms of uveitis. New targets for immunomodulation. Arch Ophthalmol. 1997; 115: 520–525, [PUBMED], [INFOTRIEVE], [CSA]
- Kotaniemi K, Aho K, Kotaniemi A. Uveitis as a cause of visual loss in arthritides and comparable conditions. J Rheumatol. 2001; 28: 309–312, [PUBMED], [INFOTRIEVE], [CSA]
- Kiss S, Letko E, Qamruddin S, Baltatzis S, Foster C S. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome. Ophthalmology 2003; 110: 1764–1769, [PUBMED], [INFOTRIEVE], [CSA]
- Howes E L, Jr, Hoffman M A, Ulevitch R J, Mathison J C, Morrison D C. Ocular localization of circulating bacterial lipopolysaccharide. Exp Eye Res. 1984; 38: 379–389, [PUBMED], [INFOTRIEVE], [CSA]
- Fox A, Hammer M E, Lill P, Burch T G, Burrish G. Experimental uveitis elicited by peptidoglycan-polysaccharide complexes, lipopolysaccharide, and muramyl dipeptide. Arch Ophthalmol. 1984; 102: 1063–1067, [PUBMED], [INFOTRIEVE], [CSA]
- Kufoy E A, Fox K, Fox A, Parks C, Pakalnis V A. Modulation of the blood-aqueous barrier by gram positive and gram negative bacterial cell wall components in the rat and rabbit. Exp Eye Res. 1990; 50: 189–195, [PUBMED], [INFOTRIEVE], [CSA]
- Rosenbaum J T, McDevitt O H, Guss R B, Egbert P R. Endotoxin-induced uveitis in rats as a model for human disease. Nature. 1980; 286: 611–613, [PUBMED], [INFOTRIEVE], [CSA]
- Rosenbaum J T, Han Y B, Park J M, Kennedy M, Planck S R. IL-1 and TNF-α in endotoxin-induced uveitis: studies in cytokine deficient receptor mice. J Rheumatol. 1998; 25: 2408–2416, [PUBMED], [INFOTRIEVE], [CSA]
- Brito B E, O'Rourke L M, Pan Y, Anglin J, Planck S R, Rosenbaum J T. IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis. Invest Ophthalmol Vis Sci. 1999; 40: 2583–2589, [PUBMED], [INFOTRIEVE], [CSA]
- Brito B E, O'Rourke L, Pan Y, Huang X, Park J M, Zamora D, Planck S, Rosenbaum J T. Murine endotoxin-induced uveitis, but not immune complex-induced uveitis, is dependent on IL-8 receptor homolog. Curr Eye Res. 1999; 19: 76–85, [PUBMED], [INFOTRIEVE], [CSA]
- Hoekzema R, Verhagen C, van Haren M, Kijlstra A. Endotoxin-induced uveitis in the rat. The significance of intraocular interleukin-6. Invest Ophthalmol Vis Sci. 1992; 33: 532–539, [PUBMED], [INFOTRIEVE], [CSA]
- Franks W L, Limb G A, Standford M R, Ogilvie J, Wolstencroft R A, Chignell A H, Dumonde D C. Cytokines in human intraocular inflammation. Curr Eye Res. 1992; 11: 187–191, [PUBMED], [INFOTRIEVE], [CSA]
- Murray P I, Hoekzema R, van Haren M AC, de Hon F D, Kijlstra A. Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci. 1990; 31: 917–920, [PUBMED], [INFOTRIEVE], [CSA]
- Goureau O, Bellot J, Thillaye B, Courtois Y, Kozak Y. Increased nitric oxide production in endotoxin-induced uveitis. Reduction of uveitis by an inhibitor of nitric oxide synthase. J Immunol. 1995; 154: 6518–6523, [PUBMED], [INFOTRIEVE], [CSA]
- Tilton R G, Chang K, Corbett J A, Misko T P, Currie M G, Bora N S, Kaplan H J, Williamson J R. Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest Ophthalmol Vis Sci. 1994; 35: 3278–3288, [PUBMED], [INFOTRIEVE], [CSA]
- Becquet F, Courtois Y, Goureau O. Nitric oxide in the eye: multifacet roles and diverse outcomes. Surv Ophthalmol. 1997; 42: 71–82, [PUBMED], [INFOTRIEVE], [CSA]
- Tobias P, Soldau K, Ulevitch R. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med. 1986; 164: 777–793, [PUBMED], [INFOTRIEVE], [CSA]
- Wright S, Tobias P S, Ulevicht R J, Ramos R A. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med. 1989; 170: 1231–1241, [PUBMED], [INFOTRIEVE], [CSA]
- Wright S D, Ramos R A, Tobias P S, Ulevitch R J, Mathison J C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990; 249: 1431–1433, [PUBMED], [INFOTRIEVE], [CSA]
- Stelter F. Structure/function relationships of CD14. Chem Immunol. 2000; 74: 25–41, [PUBMED], [INFOTRIEVE], [CSA]
- Ziegler-Heitbrock H WL, Ulevitch R J. CD14: cell surface receptor and differentiation marker. Immunol Today. 1993; 14: 121–125, [PUBMED], [INFOTRIEVE], [CSA]
- Wright S D. Toll, a new piece in the puzzle of innate immunity. J Exp Med. 1999; 189: 605–609, [PUBMED], [INFOTRIEVE], [CSA]
- Kirschning C J, Wesche H, Merrill Ayers T, Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med. 1998; 188: 2091–2097, [PUBMED], [INFOTRIEVE], [CSA]
- Brito B E, Zamora D, Bonnah R A, Pan Y, Planck S R, Rosenbaum J T. Toll-like receptor 4 and CD14 expression in human ciliary body and TLR4 in human iris endothelial cells. Exp Eye Res 2004; 79: 203–208, [PUBMED], [INFOTRIEVE], [CSA]
- Ayo C A. A toxic ocular reaction. I. New property of Shwartzman toxins. J Immunol. 1943; 46: 113–125, [CSA]
- Howes E L, Jr, Aronson S B, McKay D G. Ocular vascular permeability: effect of systemic administration of bacterial endotoxin. Arch Ophthalmol. 1970; 84: 360–367, [PUBMED], [INFOTRIEVE], [CSA]
- Howes E L, Jr, Goldyne M E, Perez D, Golstein I M, Rosenbaum J T. Lipopolysaccharide tolerance inhibits eye inflammation. I. Reduced immune complex or lipopolysaccharide effects. Arch Ophthalmol. 1985; 103: 257–260, [PUBMED], [INFOTRIEVE], [CSA]
- Verdon C P, Bruton B A, Prior R L. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 1995; 224: 502–508, [PUBMED], [INFOTRIEVE], [CSA]
- Aarden L A, De Groot E R, Schaap O L, Landorp P M. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987; 17: 1411–1416, [PUBMED], [INFOTRIEVE], [CSA]
- Rosenbaum J T, Boney R S. Activity of an interleukin-1 receptor antagonist in rabbit models of uveitis. Arch Ophthalmol. 1992; 110: 547–549, [PUBMED], [INFOTRIEVE], [CSA]
- de Vos A F, van Haren M AC, Verhagen C, Hoekzema R, Kijlstra A. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci. 1994; 35: 1100–1106, [PUBMED], [INFOTRIEVE], [CSA]
- Moser R, Schleiffenbaum B, Gorscurth P, Fehr J. Interleukin-1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest. 1980; 83: 444–456, [CSA]
- Claudio L, Martiney J A, Brosman C F. Ultrastructure studies of the blood-retina barrier after exposure to interleukin-1 or tumor necrosis factor-α. Lab Invest. 1994; 70: 850–861, [PUBMED], [INFOTRIEVE], [CSA]
- Rosenbaum J T, Kievit P, Han Y B, Park J M, Planck S R. Interleukin-6 does not mediate endotoxin-induced uveitis in mice: studies in gene deletion animals. Invest Ophthalmol Vis Sci. 1998; 39: 64–69, [PUBMED], [INFOTRIEVE], [CSA]
- Bamforth S D, Lightman S, Greenwood J. The effect of TNF-alpha and IL-6 on the permeability of the rat blood-retinal barrier in vivo. Acta Neuropathol. 1996; 9: 624–632, [CSA]
- Harju K, Glumoff V, Hallman M. Ontogeny of toll-like receptors TLR2 and TLR4 in mice. Pediatr Res. 2001; 49: 81–83, [PUBMED], [INFOTRIEVE], [CSA]